FCNC.A reports Q1 results on April 30 with options traders sending their most cautious signal in nearly a year.
The options market tells the clearest story. The put/call ratio has climbed to 0.92, more than 2.5 standard deviations above its 20-day average of 0.80 — the highest defensive reading in twelve months. That spike reflects a meaningful shift in hedging demand that has built steadily over the past two weeks, even as the stock recovered 2.2% on Monday to close at $1,973.53. The one-week picture is less comfortable: the stock is down 4.3% on the week, lagging most of its regional bank peers, which fell 0.3%–2.3% over the same period. Short interest offers a partial offset — it dipped 3.6% on April 24 to 5.2% of the float, and borrow costs remain negligible at 0.63%, with utilization at 26%, well below the 52-week peak of 33%. The lending market is not under stress.
The analyst community is trimming rather than abandoning. JP Morgan downgraded the stock to Neutral at the start of April, cutting its target from $2,450 to $2,200 — a meaningful step back from a bellwether firm. TD Cowen followed this week, lowering its target to $2,300 while holding its Buy rating, and JP Morgan trimmed again on April 24 to $2,150. The consensus mean target of $2,213 still implies roughly 12% upside from current levels, but the direction of travel is clearly lower. Bulls point to 9.9% loan growth and the SVB acquisition's potential to accelerate NIM recovery through faster repayment of the $35 billion fixed-rate note. Bears focus on the opposite side of that same trade: a shrinking balance sheet, deposit contraction, and NII pressure are pulling 2026 earnings estimates down. The 12-month forward EPS growth estimate ranks in the 95th percentile of the universe, yet near-term EPS momentum scores sit in the bottom quintile — a gap that the print will need to address.
Ownership adds an interesting wrinkle. BlackRock added roughly 1.1 million shares in Q1, lifting its position to 19.1% — a substantial commitment. Infrastructure Capital Advisors entered as a new holder with 18.2% of shares, an eye-catching addition given the concentrated register. The Holding family retains 12.4%. Insider activity is modest and net positive: a director added $21,000 worth of shares in March, a continuation of small but consistent open-market buying stretching back through 2025. After the January print, the stock rose 3.2% on the day and 6.3% over the following week. The most recent comparable — a Q1 event recorded in April — showed a 5.6% one-day decline, though the data there appears to capture a single event with multiple timestamps and should be read with caution.
The earnings report on April 30 is therefore less about loan growth, which has been solid, and more about whether NIM is recovering fast enough to offset deposit pressure and rising expenses at a pace that justifies a stock now trading at 10.6x earnings and near book value.
See the live data behind this article on ORTEX.
Open FCNC.A on ORTEX →ORTEX Market Intelligence content is generated by AI from a snapshot of ORTEX's proprietary data. Content is informational only and does not constitute investment advice.
